We are live on ! Find out more
PRVA icon

Privia Health

234 hedge funds and large institutions have $2.18B invested in Privia Health in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 79 increasing their positions, 89 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,256% more call options, than puts

Call options by funds: $4.97M | Put options by funds: $211K

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

6% more capital invested

Capital invested by funds: $2.05B → $2.18B (+$130M)

4% more funds holding

Funds holding: 225234 (+9)

1.29% more ownership

Funds ownership: 98.86%100.15% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 89

Holders
234
Holders Change
+9
Holders Change %
+4%
% of All Funds
3.36%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
79
Reduced
89
Closed
21
Calls
$4.97M
Puts
$211K
Net Calls
+$4.76M
Net Calls Change
-$205K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$331M +$5.18M +271,645 +2%
BlackRock
2
BlackRock
New York
$329M +$14.8M +773,755 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$216M -$1.76M -92,152 -0.8%
DCP
4
Durable Capital Partners
Maryland
$202M +$38.5M +2,018,679 +22%
RF
5
Rubicon Founders
Tennessee
$105M
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$99M +$1.56M +81,620 +2%
RP
7
Riverbridge Partners
Minnesota
$88.6M -$5.35M -280,177 -5%
State Street
8
State Street
Massachusetts
$75.8M -$744K -39,008 -0.9%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$64M -$36.7M -1,922,875 -35%
Principal Financial Group
10
Principal Financial Group
Iowa
$59.2M -$1.61M -84,342 -3%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$47.1M -$5.6M -293,566 -10%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$44M +$442K +23,178 +1%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$23.3M +$3.03M +158,869 +14%
Franklin Resources
14
Franklin Resources
California
$23.1M +$543K +28,480 +2%
N
15
Nuveen
North Carolina
$22.6M +$15.2M +795,678 +178%
Northern Trust
16
Northern Trust
Illinois
$22.2M -$2.23M -117,049 -9%
Charles Schwab
17
Charles Schwab
California
$19.4M +$1.24M +65,152 +7%
BG
18
Bellevue Group
Switzerland
$19.3M
Morgan Stanley
19
Morgan Stanley
New York
$19M +$4.62M +242,068 +30%
Bank of America
20
Bank of America
North Carolina
$17.7M +$1.57M +82,374 +9%
Loomis, Sayles & Company
21
Loomis, Sayles & Company
Massachusetts
$16.7M -$30K -1,572 -0.2%
UBS AM
22
UBS AM
Illinois
$15M -$104K -5,461 -0.7%
EAM
23
Eventide Asset Management
Massachusetts
$15M +$14.2M +746,231 +979%
SFM
24
Soros Fund Management
New York
$13.7M +$2.86M +150,000 +25%
CWG
25
C WorldWide Group
Denmark
$11.1M

PRVA Hedge Fund Activity: Q3 2024 in Review

234 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q3 2024, worth a combined $2.18B — up 6.3% from $2.05B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PRVA positions and 21 closed out — a net gain of 10 holders — while 79 added to existing stakes and 89 trimmed.

The largest buyer was Durable Capital Partners, adding an estimated $38.5M. The largest seller was Wellington Management Group, cutting an estimated $36.7M.

  • 234 institutional investors held Privia Health (PRVA) as of Q3 2024, up from 225 in Q2 2024.
  • Funds reported $2.18B of Privia Health stock for Q3 2024, up 6.3% quarter-over-quarter.
  • 31 funds opened new Privia Health positions in Q3 2024 and 21 closed out, a net change of +10 holders.
  • The largest Privia Health buyer in Q3 2024 was Durable Capital Partners, an estimated $38.5M added.
  • The largest Privia Health seller in Q3 2024 was Wellington Management Group, an estimated $36.7M sold.

Based on aggregated 13F filings for Q3 2024.